Charlotte Bunne on developing AI-based diagnostic tools

Charlotte Bunne, head of EPFL's Artificial Intelligence in Molecular Medicine Group, is developing AI algorithms to better understand the incredibly complex and high-dimensional data that represent the hundreds of tissue layers and protein markers in an individual cell. EPFL magazine Dimensions spoke to Charlotte Bunne about her work at the cutting-edge of AI in medicine and biology. Could you describe the focus of your research? We are developing diagnostic tools for clinics that are driven by AI technologies. This includes forecasting the best treatment that a patient should receive, trying to understand the state of disease that a patient is in, and deciphering important biomarkers or potential drug targets that we should investigate further.